World News: 16:46 GMT Tuesday 13th March 2018. [Valneva via Globe Newswire via SPi World News]
Lyon France March 13 2018 - Valneva SE a fully integrated commercial stage biotech company focused on developing innovative lifesaving vaccines, today announced the initiation of a Phase I clinical trial in the US to evaluate the safety and immunog...
Globe Newswire: 16:46 GMT Tuesday 13th March 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.